Literature DB >> 31640411

Reproducibility of Fixed-luminance and Multi-luminance Flicker Electroretinography in Patients With Diabetic Retinopathy Using an Office-based Testing Paradigm.

John J Wroblewski1, Christa McChancy1, Kassandra Pickel2, Hunter Buterbaugh1, Tyler Wieland1, Alberto Gonzalez2.   

Abstract

BACKGROUND: We evaluated the reproducibility of office-based flicker electroretinography (ERG) in patients with nonproliferative diabetic retinopathy (NPDR).
METHODS: An observational study was conducted in which ultra-widefield fluorescein angiography (UWF-FA) was performed on 20 patients with mild-to-moderate NPDR; images were graded by the Fundus Photography Reading Center (Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI, USA). Fixed- and multi-luminance flicker ERG was repeated four times (greater than or equal to seven days apart). Recording consistency was assessed using intra-class correlation coefficients (ICCs), coefficients of variation, and Pearson correlations.
RESULTS: 82.5% and 17.5% of eyes had mild and moderate NPDR using UWF-FA; 90% of the angiograms were given a high confidence grade. Fixed-luminance phase values were highly reproducible (ICC: 0.949; P < .001). There was a significant negative correlation between fixed-luminance phase and log-corrected ischemic index values (-0.426; P = .015).
CONCLUSIONS: Office-based, fixed-luminance phase values are highly reproducible and negatively correlate with retinal ischemia in NPDR, suggesting that global retinal dysfunction may be reliably quantified early in patients with diabetes.

Entities:  

Keywords:  diabetic retinopathy; diagnostic testing; flicker electroretinography retinal dysfunction; ultra-widefield fluorescein angiography

Year:  2019        PMID: 31640411      PMCID: PMC7645135          DOI: 10.1177/1932296819882719

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  63 in total

1.  Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy.

Authors:  André Messias; José Afonso Ramos Filho; Katharina Messias; Felipe P P Almeida; Rogério A Costa; Ingrid U Scott; Florian Gekeler; Rodrigo Jorge
Journal:  Doc Ophthalmol       Date:  2012-03-29       Impact factor: 2.379

2.  Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy.

Authors:  Amélie Lecleire-Collet; Isabelle Audo; Mounir Aout; Jean-François Girmens; Rénata Sofroni; Ali Erginay; Jean-François Le Gargasson; Saddek Mohand-Saïd; Taly Meas; Pierre-Jean Guillausseau; Eric Vicaut; Michel Paques; Pascale Massin
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-02       Impact factor: 4.799

3.  WIDE-FIELD SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY.

Authors:  Francesco Pichi; Paola Carrai; Francesco Bonsignore; Edoardo Villani; Antonio P Ciardella; Paolo Nucci
Journal:  Retina       Date:  2015-12       Impact factor: 4.256

4.  Electrophysiological changes in juvenile diabetics without retinopathy.

Authors:  S Juen; G F Kieselbach
Journal:  Arch Ophthalmol       Date:  1990-03

5.  Deep Retinal Capillary Nonperfusion Is Associated With Photoreceptor Disruption in Diabetic Macular Ischemia.

Authors:  Fabio Scarinci; Peter L Nesper; Amani A Fawzi
Journal:  Am J Ophthalmol       Date:  2016-05-10       Impact factor: 5.258

6.  ULTRAHIGH SPEED SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF RETINAL AND CHORIOCAPILLARIS ALTERATIONS IN DIABETIC PATIENTS WITH AND WITHOUT RETINOPATHY.

Authors:  WooJhon Choi; Nadia K Waheed; Eric M Moult; Mehreen Adhi; ByungKun Lee; Talisa De Carlo; Vijaysekhar Jayaraman; Caroline R Baumal; Jay S Duker; James G Fujimoto
Journal:  Retina       Date:  2017-01       Impact factor: 4.256

7.  Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.

Authors:  David M Brown; Ursula Schmidt-Erfurth; Diana V Do; Frank G Holz; David S Boyer; Edoardo Midena; Jeffrey S Heier; Hiroko Terasaki; Peter K Kaiser; Dennis M Marcus; Quan D Nguyen; Glenn J Jaffe; Jason S Slakter; Christian Simader; Yuhwen Soo; Thomas Schmelter; George D Yancopoulos; Neil Stahl; Robert Vitti; Alyson J Berliner; Oliver Zeitz; Carola Metzig; Jean-François Korobelnik
Journal:  Ophthalmology       Date:  2015-07-18       Impact factor: 12.079

8.  Photopic full-field electroretinography and optical coherence tomography in type 1 diabetic retinopathy.

Authors:  Ragnhild Wivestad Jansson; Maria Baroy Raeder; Jørgen Krohn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-26       Impact factor: 3.117

9.  Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections.

Authors:  Ariana M Levin; Irene Rusu; Anton Orlin; Mrinali P Gupta; Peter Coombs; Donald J D'Amico; Szilárd Kiss
Journal:  Clin Ophthalmol       Date:  2017-01-21

10.  The macular function and structure in patients with diabetic macular edema before and after ranibizumab treatment.

Authors:  Barbara Nowacka; Marta Kirkiewicz; Katarzyna Mozolewska-Piotrowska; Wojciech Lubiński
Journal:  Doc Ophthalmol       Date:  2016-03-21       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.